Device Industry Y2K Preparation Efforts Pay Off With Few Glitches
This article was originally published in The Gray Sheet
Executive Summary
A handful of minor problems related to the year 2000 calendar conversion, reported primarily outside the U.S. since the turn of the century, has done little to detract from an overall perception that the device industry has sailed through the year change essentially unscathed.
You may also be interested in...
Senate Committee Lambastes Industry Response To FDA Year 2000 Initiative
The lukewarm response by medical device manufacturers to FDA's call for information related to year 2000 compliance could jeopardize the industry's Y2K "shield" from liability claims, Sen. Christopher Dodd (D-Conn.) warned at a July 23 hearing of the Senate Special Committee on the Year 2000 Problem.
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.